148 related articles for article (PubMed ID: 6811956)
21. Inhibition of ornithine decarboxylase with 2-difluoromethylornithine: reduced incidence of dimethylhydrazine-induced colon tumors in mice.
Kingsnorth AN; King WW; Diekema KA; McCann PP; Ross JS; Malt RA
Cancer Res; 1983 Jun; 43(6):2545-9. PubMed ID: 6406047
[TBL] [Abstract][Full Text] [Related]
22. Effect of concentration of D,L-2-difluoromethylornithine on murine mammary carcinogenesis.
Thompson HJ; Meeker LD; Herbst EJ; Ronan AM; Minocha R
Cancer Res; 1985 Mar; 45(3):1170-3. PubMed ID: 3918790
[TBL] [Abstract][Full Text] [Related]
23. Polyamines as mediators of estrogen action on the growth of experimental breast cancer in rats.
Manni A; Wright C
J Natl Cancer Inst; 1984 Aug; 73(2):511-4. PubMed ID: 6431170
[TBL] [Abstract][Full Text] [Related]
24. Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on polyamine levels in rat tissues.
Danzin C; Jung MJ; Grove J; Bey P
Life Sci; 1979 Feb; 24(6):519-24. PubMed ID: 431333
[No Abstract] [Full Text] [Related]
25. Inhibition of ileal and colonic ornithine decarboxylase activity by alpha-difluoromethylornithine in rats: transient atrophic changes and loss of postresectional adaptive growth.
Kingsnorth AN; Abu-Khalaf M; LaMuraglia GM; McCann PP; Diekema KA; Ross JS; Malt RA
Surgery; 1986 Jun; 99(6):721-7. PubMed ID: 2424111
[TBL] [Abstract][Full Text] [Related]
26. In vivo effects of DL-alpha-difluoromethylornithine on the polyamine and nucleotide phosphate metabolism in P388/S leukemia cells.
Kremmer T; Boldizsár M; Holczinger L
Exp Cell Biol; 1986; 54(1):8-15. PubMed ID: 3082689
[TBL] [Abstract][Full Text] [Related]
27. L-Ornithine decarboxylase:an essential role in early mammalian embryogenesis.
Fozard JR; Part ML; Prakash NJ; Grove J; Schechter PJ; Sjoerdsma A; Koch-Weser J
Science; 1980 May; 208(4443):505-8. PubMed ID: 6768132
[TBL] [Abstract][Full Text] [Related]
28. alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.
Weeks CE; Herrmann AL; Nelson FR; Slaga TJ
Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6028-32. PubMed ID: 6821130
[TBL] [Abstract][Full Text] [Related]
29. Implication of ornithine decarboxylase and polyamines in pancreatic growth of neonatal rats.
Morisset J; Grondin G
Pancreas; 1987; 2(3):303-11. PubMed ID: 3114741
[TBL] [Abstract][Full Text] [Related]
30. Aminoguanidine reversal of the inhibitory effects of ornithine analogs on the in vitro clonogenic survival of the R3327AT prostate-derived tumor.
Heston WD; Lazan DW; Fair WR
Cancer Lett; 1981 Feb; 11(4):323-30. PubMed ID: 6794904
[TBL] [Abstract][Full Text] [Related]
31. Reversal of alpha-difluoromethylornithine inhibition of caerulein-induced pancreatic growth by putrescine.
Morisset J; Benrezzak O
Regul Pept; 1985 Jul; 11(3):201-8. PubMed ID: 3933061
[TBL] [Abstract][Full Text] [Related]
32. Effects of difluoromethylornithine on proliferation, polyamine content and plating efficiency of cultured human carcinoma cells.
Seidenfeld J
Cancer Chemother Pharmacol; 1985; 15(3):196-202. PubMed ID: 3931927
[TBL] [Abstract][Full Text] [Related]
33. Polyamine biosynthesis and skin tumor promotion: inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin tumor formation by the irreversible inhibitor of ornithine decarboxylase alpha-difluoromethylornithine.
Takigawa M; Verma AK; Simsiman RC; Boutwell RK
Biochem Biophys Res Commun; 1982 Apr; 105(3):969-76. PubMed ID: 6807316
[No Abstract] [Full Text] [Related]
34. Independent induction and inhibition of ornithine decarboxylase and aryl hydrocarbon hydroxylase activities in rat epidermis.
Raunio H; Pelkonen O
J Invest Dermatol; 1982 Oct; 79(4):246-9. PubMed ID: 6813381
[TBL] [Abstract][Full Text] [Related]
35. Effect of difluoromethylornithine on host and tumor polyamine metabolism during total parenteral nutrition.
Harris WB; Grossie VB; Ota DM; Nishioka K; Ajani JA; Chang T; Patenia D
J Surg Res; 1985 Jun; 38(6):592-8. PubMed ID: 3925242
[TBL] [Abstract][Full Text] [Related]
36. Potentiation of methylglyoxal-bis-guanylhydrazone by alpha-difluoromethylornithine in rat prostate cancer.
Herr HW; Kleinert EL; Relyea NM; Whitmore WF
Cancer; 1984 Mar; 53(6):1294-8. PubMed ID: 6420041
[TBL] [Abstract][Full Text] [Related]
37. Effects of inhibitors of ornithine and S-adenosylmethionine decarboxylases on L6 myoblast proliferation.
Stoscheck CM; Erwin BG; Florini JR; Richman RA; Pegg AE
J Cell Physiol; 1982 Feb; 110(2):161-8. PubMed ID: 6802862
[TBL] [Abstract][Full Text] [Related]
38. Effects of alpha-difluoromethylornithine on the growth of experimental Wilms' tumor and renal adenocarcinoma.
Kingsnorth AN; McCann PP; Diekema KA; Ross JS; Malt RA
Cancer Res; 1983 Sep; 43(9):4031-4. PubMed ID: 6307502
[TBL] [Abstract][Full Text] [Related]
39. Further studies on difluoromethylornithine in African trypanosomes.
McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
[TBL] [Abstract][Full Text] [Related]
40. Role of polyamines in isoproterenol-induced cardiac hypertrophy: effects of alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase.
Bartolome JV; Trepanier PA; Chait EA; Slotkin TA
J Mol Cell Cardiol; 1982 Aug; 14(8):461-6. PubMed ID: 6217347
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
